Showing results (521-530 of 669) with videos related to

Sort By:
Pageof 67
Hemasphere|October 7, 2025
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levelsWassilis S C Bruins, Febe Smits, Carolien Duetz, et al.
Hemasphere|October 13, 2025
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platformAdrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino, et al.
Hemasphere|September 29, 2025
Transcriptome profiling of megakaryocytes and platelets: Application to GP9- and IKZF5-related thrombocytopeniaKoenraad De Wispelaere, Fabienne Ver Donck, Kato Ramaekers, et al.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.
Hemasphere|January 26, 2023
Abnormal Platelet Counts and Clonal Hematopoiesis in the General PopulationPriscilla Kamphuis, Maaike G J M van Bergen, Isabelle A van Zeventer, et al.
Hemasphere|January 25, 2020
Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging StrategiesUlrich Germing, Ester N Oliva, Devendra Hiwase, et al.
Hemasphere|November 21, 2022
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic DiseasesDavor Galusic, Sandra Basic-Kinda, Andela Pijuk, et al.
Hemasphere|June 24, 2022
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host DiseaseAna Zelic Kerep, Filip Pirsl, Seth Steinberg, et al.
Hemasphere|June 24, 2022
Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in PhenotypeFerdows Atiq, Johan Boender, Waander L van Heerde, et al.
Hemasphere|February 2, 2022
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer RegistryRuth Wester, Avinash G Dinmohamed, Bronno van der Holt, et al.
Pageof 67